EUVIMEDEUVIMED entdecken
Crossref

Cost-Effectiveness Analysis of Amifostine (Ethyol©) in Patients with Non-Small Cell Lung Cancer

Daniel R. Touchette, J. G. Stevenson, Gail Jensen

Journal of Aging & Pharmacotherapy · 2006-01 · 13 (2) · 109-126

DOI: 10.3109/j397v13n02_09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Aging & Pharmacotherapy, online erschienen am 04.12.2011. Verfasst von Daniel R. Touchette und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Touchette, D. R., Stevenson, J. G., & Jensen, G. (2006). Cost-Effectiveness Analysis of Amifostine (Ethyol©) in Patients with Non-Small Cell Lung Cancer. Journal of Aging & Pharmacotherapy, 13(2), 109-126. https://doi.org/10.3109/j397v13n02_09

Vancouver

Touchette DR, Stevenson JG, Jensen G. Cost-Effectiveness Analysis of Amifostine (Ethyol©) in Patients with Non-Small Cell Lung Cancer. Journal of Aging & Pharmacotherapy. 2006;13(2):109-126. doi:10.3109/j397v13n02_09

BibTeX
@article{Touchette2006,
  author = {Touchette, Daniel R. and Stevenson, J. G. and Jensen, Gail},
  title = {Cost-Effectiveness Analysis of Amifostine (Ethyol©) in Patients with Non-Small Cell Lung Cancer},
  journal = {Journal of Aging & Pharmacotherapy},
  year = {2006},
  volume = {13},
  number = {2},
  pages = {109--126},
  doi = {10.3109/j397v13n02_09}
}
Kostenlos starten →